{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:33:31Z","timestamp":1787625211157,"version":"build-2736575974"},"reference-count":26,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"3","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>Introducci\u00f3n. La infecci\u00f3n genital por Chlamydia trachomatis es una de las m\u00e1s frecuentes en el mundo. Cada a\u00f1o se registran cerca de 85 millones de nuevos casos de esta enfermedad, que cursa con graves complicaciones en la mujer y reci\u00e9n nacido.Objetivo. Determinar las caracter\u00edsticas cl\u00ednico-epidemiol\u00f3gicas de la infecci\u00f3n por C. trachomatis en mujeres venezolanas sexualmente activas.Materiales y m\u00e9todos. Es un estudio descriptivo, transversal y de campo, sustentado en la historia cl\u00ednica y el examen f\u00edsico, la detecci\u00f3n de infecci\u00f3n con la prueba inmunoenzim\u00e1tica con anticuerpos policlonales anti-LPS y la confirmaci\u00f3n de los resultados con la de biolog\u00eda molecular. La muestra estuvo conformada por 100 mujeres sexualmente activas mayores de 12 a\u00f1os de edad, del estado Carabobo, Venezuela.Resultados. La mayor\u00eda de las mujeres se encontraba entre los 20 y los 45 a\u00f1os de edad. En el 25 % de las mismas, se detectaron anticuerpos IgG anti-C. trachomatis y, en el 84 % de estas, se confirm\u00f3 la infecci\u00f3n mediante PCR; en ninguna de las mujeres se hallaron anticuerpos IgM anti-C. trachomatis.Conclusi\u00f3n. La infecci\u00f3n cr\u00f3nica predomina en las mujeres entre los 20 y los 45 a\u00f1os de edad; la prueba inmunoenzim\u00e1tica arroj\u00f3 falsos positivos corroborados por PCR.<\/jats:p>","DOI":"10.7705\/biomedica.6246","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T19:09:32Z","timestamp":1663614572000},"page":"522-530","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Detecci\u00f3n de infecci\u00f3n por Chlamydia trachomatis en mujeres sexualmente activas en Venezuela"],"prefix":"10.7705","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9064-6942","authenticated-orcid":false,"given":"Milagros","family":"Joya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8625-521X","authenticated-orcid":false,"given":"Ricardo","family":"Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4981-4166","authenticated-orcid":false,"given":"Daniel","family":"Bastidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5805-6926","authenticated-orcid":false,"given":"Gilberto","family":"Bastidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"109893","doi-asserted-by":"crossref","unstructured":"Davey J, Shull H, Billings J, Wang D, Adachi K, Klausner J. Prevalence of curable sexually transmitted infections in pregnant women in low- and middle-income countries from 2010 to 2015: A systematic review. Sex Transm Dis. 2016;43:450-8. https:\/\/doi.org\/10.1097\/OLQ.0000000000000460","DOI":"10.1097\/OLQ.0000000000000460"},{"key":"109894","doi-asserted-by":"crossref","unstructured":"Witkin S, Minis E, Athanasiou A, Leizer J, Linhares I. Chlamydia trachomatis: The persistent pathogen. Clin Vaccine Immunol. 2017;24:e00203-17. https:\/\/doi.org\/10.1128\/CVI.00203-17","DOI":"10.1128\/CVI.00203-17"},{"key":"109895","doi-asserted-by":"crossref","unstructured":"Ahmed N, Sharma A, Satpathy G, Titiyal J, Tandon R, Agarwal T, et al. Chlamydia trachomatis antigen positivity in patients with different ocular manifestations over 8 years. J Glob Infect Dis. 2018;10:16-8. https:\/\/doi.org\/10.4103\/jgid.jgid_100_17","DOI":"10.4103\/jgid.jgid_100_17"},{"key":"109896","doi-asserted-by":"crossref","unstructured":"Janssen K, Dirks J, Dukers-Muijrers N, Hoebe C, Wolffs P. Review of Chlamydia trachomatis viability methods: Assessing the clinical diagnostic impact of NAAT positive results. Expert Rev Mol Diagn. 2018;18:739-47. https:\/\/doi.org\/10.1080\/14737159.2018.1498785","DOI":"10.1080\/14737159.2018.1498785"},{"key":"109897","unstructured":"Bianchi S, Frati E, Canuti M, Colzani D, Fasoli E, Amendola A, et al. Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18-25 years) in Milan, Italy. J Prev Med Hyg. 2016;57:E128-34."},{"key":"109898","doi-asserted-by":"crossref","unstructured":"Ditkowsky J, Shah K, Hammerschlag M, Kohlhoff S, Smith-Norowitz T. Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States. BMC Infect Dis. 2017;17:155. https:\/\/doi.org\/10.1186\/s12879-017-2248-5","DOI":"10.1186\/s12879-017-2248-5"},{"key":"109899","unstructured":"Garc\u00eda A, Ara\u00faz P, Taylor L, Moraga M, Herrera G. Infecci\u00f3n por Chlamydia trachomatis en un grupo de mujeres de alto riesgo. Trabajadoras del sexo en Costa Rica. Rev Costarric Cienc M\u00e9d. 2005;26:15-29."},{"key":"109900","unstructured":"Joya M, Joya A, Sequera M, Arteaga E, Bastidas G. Prevalencia de la infecci\u00f3n por Chlamydia trachomatis en hombres inf\u00e9rtiles. MedULA. 2014;23:29-32."},{"key":"109901","doi-asserted-by":"crossref","unstructured":"Goggins E, Chamberlain A, Kim T, Young M, Jamieson J, Haddad L. Patterns of screening, infection, and treatment of Chlamydia trachomatis and Neisseria gonorrhea in pregnancy. Obstet Gynecol. 2020;135:799-807. https:\/\/doi.org\/10.1097\/AOG.0000000000003757","DOI":"10.1097\/AOG.0000000000003757"},{"key":"109902","unstructured":"Arteaga B, Messina C, Rocha E, Chac\u00f3n E, Rodulfo F. Factores de riesgo de la infecci\u00f3n por Chlamydia trachomatis en lactantes menores de 6 meses: estudio prospectivo Hospital Dr. Leopoldo Manrique Terrero, Caracas, Venezuela. Marzo 1995-octubre 1996. Arch Venez Pueric Pediatr. 1996:60:112-6."},{"key":"109903","doi-asserted-by":"crossref","unstructured":"Joolayi F, Navidifar T, Mohammad R, Amin M. Comparison of Chlamydia trachomatis infection among infertile and fertile women in Ahvaz, Iran: A case-control study. Int J Reprod Biomed (Yazd). 2017;15:713-8.","DOI":"10.29252\/ijrm.15.11.713"},{"key":"109904","doi-asserted-by":"crossref","unstructured":"Kiguen A, Marram\u00e1 M, Ruiz S, Estofan P, Venezuela R, Mosmann J, et al. Prevalence, risk factors and molecular characterization of Chlamydia trachomatis in pregnant women from C\u00f3rdoba, Argentina: A prospective study. PLoS ONE. 2019;14:e0217245. https:\/\/doi.org\/10.1371\/journal.pone.0217245","DOI":"10.1371\/journal.pone.0217245"},{"key":"109905","doi-asserted-by":"crossref","unstructured":"Zambrano A, Mu\u00f1oz B, Mkocha H, Dize L, Gaydos C, Quinn T, et al. Measuring trachomatous inflammation-intense (TI) when prevalence is low provides data on infection with Chlamydia trachomatis. Invest Ophthalmol Vis Sci. 2017;58:997-1000. https:\/\/doi.org\/10.1167\/iovs.16-20421","DOI":"10.1167\/iovs.16-20421"},{"key":"109906","unstructured":"Ministerio del Poder Popular para la Salud. Alertas epidemiol\u00f3gicas. Direcci\u00f3n de Epidemiolog\u00eda y An\u00e1lisis Estad\u00edstico. Direcci\u00f3n de Vigilancia Epidemiol\u00f3gica. 2018. Fecha de consulta: 12 de enero de 2021. Disponible en: https:\/\/drive.google.com\/drive\/u\/1\/folders\/13Ol7SAQXa7ofU-HQ9XSP9mELHES07O9K"},{"key":"109907","doi-asserted-by":"crossref","unstructured":"Olson-Chen C, Balaram K, Hackney D. Chlamydia trachomatis and adverse pregnancy outcomes: Meta-analysis of patients with and without infection. Matern Child Health J. 2018;22:812-21. https:\/\/doi.org\/10.1007\/s10995-018-2451-z","DOI":"10.1007\/s10995-018-2451-z"},{"key":"109908","doi-asserted-by":"crossref","unstructured":"de Cetina T, Polanco-Reyes L, Fern\u00e1ndez-Gonz\u00e1lez V, Ruiz-Garc\u00eda S. Infecci\u00f3n por Chlamydia trachomatis en usuarias de dos cl\u00ednicas de planificaci\u00f3n familiar. Salud P\u00fablica M\u00e9x. 2003;45:S657-61.","DOI":"10.1590\/S0036-36342003001100011"},{"key":"109909","doi-asserted-by":"crossref","unstructured":"Poussin M, Fuentes V, Corbel C, Prin L, Eb F, Orfila J. Captura-ELISA; un nuevo ensayo para la detecci\u00f3n de anticuerpos de inmunoglobulina isotipo M utilizando ant\u00edgeno Chlamydia trachomatis. J Immunol Methods. 1997;204:1-12. https:\/\/doi.org\/10.1016\/s0022-1759(97)00014-8","DOI":"10.1016\/S0022-1759(97)00014-8"},{"key":"109910","doi-asserted-by":"crossref","unstructured":"Rawre J, Juyal D, Dhawan B. Molecular typing of Chlamydia trachomatis: An overview. Indian J Med Microbiol. 2017;35:17-26. https:\/\/doi.org\/10.4103\/ijmm.IJMM_16_341","DOI":"10.4103\/ijmm.IJMM_16_341"},{"key":"109911","doi-asserted-by":"crossref","unstructured":"Frej-M\u0105drzak M, Grybo\u015b A, Grybo\u015b M, Teryks-Wo\u0142yniec D, Jama-Kmiecik A, Sarowska J, et al. PCR diagnostics of Chlamydia trachomatis in asymptomatic infection by women. Ginekol Pol. 2018;89:115-9. https:\/\/doi.org\/10.5603\/GP.a2018.0020","DOI":"10.5603\/GP.a2018.0020"},{"key":"109912","doi-asserted-by":"crossref","unstructured":"Huai P, Li F, Chu T, Liu D, Liu J, Zhang F. Prevalence of genital Chlamydia trachomatis infection in the general population: A meta-analysis. BMC Infect Dis. 2020;20:589. https:\/\/doi.org\/10.1186\/s12879-020-05307-w","DOI":"10.1186\/s12879-020-05307-w"},{"key":"109913","doi-asserted-by":"crossref","unstructured":"Giuliano A, Denman C, Guernsey J, Navarro J, Ortega L, Djambazov B, et al. Design and results of the USA-Mexico border human papillomavirus (HPV), cervical dysplasia, and Chlamydia trachomatis study. Rev Panam Salud P\u00fablica. 2001;9:172-81. https:\/\/doi.org\/10.1590\/s1020-49892001000300007","DOI":"10.1590\/S1020-49892001000300007"},{"key":"109914","doi-asserted-by":"crossref","unstructured":"Arr\u00e1iz R, Ginestre P, Perozo M, Castellano G, Urdaneta B, Garc\u00eda G. Molecular diagnosis and Chlamydia trachomatis infections prevalence in symptomatic and asymptomatic patients of a population of the Zulia State, Venezuela. Rev Chilena Infectol. 2007;24:48-52. https:\/\/doi.org\/10.4067\/s0716-10182007000100007","DOI":"10.4067\/S0716-10182007000100007"},{"key":"109915","unstructured":"Arraiz N, Ginestre M, Castellano M, Perozo A, Urdaneta B. Detecci\u00f3n de Chlamydia trachomatis en muestras de hisopado endocervical por inmunofluorescencia directa y reacci\u00f3n en cadena de la polimerasa. Rev Soc Ven Microbiol. 2006;26:14-8."},{"key":"109916","doi-asserted-by":"crossref","unstructured":"Czerwinski M, Niedzwiedzka-Stadnik M, Zielicka-Hardy A, Tomusiak A, Sadkowska-Todys M, Zielinski A, et al. Genital Chlamydia trachomatis infections in young adults a school-based bio-behavioural study in urban areas, Poland, 2012 to 2015. Euro Surveill. 2018;23:17-00087. https:\/\/doi.org\/10.2807\/1560-7917.ES.2018.23.6.17-00087","DOI":"10.2807\/1560-7917.ES.2018.23.6.17-00087"},{"key":"109917","doi-asserted-by":"crossref","unstructured":"Banniettis N, Thumu S, Weedon J, Chotikanatis K, Szigeti A, Hammerschlag M, et al. Seroprevalence of Chlamydia trachomatis in inner-city children and adolescents-implications for vaccine development. Sex Transm Dis. 2017;44:717-21. https:\/\/doi.org\/10.1097\/OLQ.0000000000000683","DOI":"10.1097\/OLQ.0000000000000683"},{"key":"109918","doi-asserted-by":"crossref","unstructured":"Frej-M\u0105drzak M, Grybo\u015b A, Grybo\u015b M, Teryks-Wo\u0142yniec D, Jama-Kmiecik A, Sarowska J, et al. PCR diagnostics of Chlamydia trachomatis in asymptomatic infection by women. Ginekol Pol. 2018;89:115-9. https:\/\/doi.org\/10.5603\/GP.a2018.0020","DOI":"10.5603\/GP.a2018.0020"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6246\/5096","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/6246\/5096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:20:27Z","timestamp":1665062427000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/6246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9,2]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.6246","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"2022-09-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Comunicaci\u00f3n breve","name":"content_type","label":"Content Type"}]}}